Lymph node removal for rectal neuroendocrine tumors during laparoscopic surgery
Part of Cancer, Digestive system clinical trials.
This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a rectal neuroendocrine tumor (either low- or high-grade) by biopsy.
- Your tumor is larger than 2 cm, or is 1-2 cm and has reached a certain depth (stage T2 or higher) or is a higher-grade (grade 3), or it came back after a previous endoscopic removal.
- You are well enough to have surgery (performance status 0 or 1 on the ECOG scale, meaning you can carry out daily activities without assistance).
- You do not have a complete bowel blockage, active hepatitis, nerve damage, major heart problems (like a recent heart attack), active infection, or a bleeding disorder.
- You are not pregnant or breastfeeding, and you do not have a history of alcohol or drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches to remove rectal cancer tissue while aiming to preserve cure chances. It may help you see which approach fits your tumor location and health situation best.
This study looks at how doctors decide to treat enlarged lymph nodes in the pelvis for rectal cancer. It aims to help guide whether surgery should remove those lymph nodes, using MRI findings to improve outcomes.
This trial compares two ways of removing lymph nodes (small glands that help fight infection) during robotic surgery for mid or low rectal cancer. It aims to see whether removing fewer lymph nodes may be just as effective and cause fewer side effects than removing a larger group of them.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
This trial focuses on rectal cancer that has come back in the side lymph nodes near the pelvis. It tests how to treat that “lateral nodal recurrence” to improve outcomes by targeting these specific lymph nodes.
Hear when a new Rectal Neuroendocrine Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.